MetLife Investment Management’s Houlihan Lokey HLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.5M | Sell |
26,110
-1,553
| -6% | -$229K | 0.02% | 839 |
|
|
2026
Q1 | $3.97M | Buy |
27,663
+39
| +0.1% | +$6.42K | 0.02% | 728 |
|
|
2025
Q4 | $4.81M | Sell |
27,624
-1,293
| -4% | -$237K | 0.02% | 644 |
|
|
2025
Q3 | $5.94M | Sell |
28,917
-991
| -3% | -$194K | 0.03% | 558 |
|
|
2025
Q2 | $5.38M | Sell |
29,908
-288
| -1% | -$48.4K | 0.03% | 547 |
|
|
2025
Q1 | $4.88M | Sell |
30,196
-203
| -0.7% | -$34.9K | 0.03% | 625 |
|
|
2024
Q4 | $5.28M | Buy |
30,399
+2,737
| +10% | +$482K | 0.03% | 527 |
|
|
2024
Q3 | $4.37M | Sell |
27,662
-115
| -0.4% | -$17.2K | 0.03% | 605 |
|
|
2024
Q2 | $3.75M | Sell |
27,777
-980
| -3% | -$128K | 0.02% | 650 |
|
|
2024
Q1 | $3.69M | Sell |
28,757
-479
| -2% | -$59.3K | 0.02% | 662 |
|
|
2023
Q4 | $3.51M | Buy |
29,236
+28,077
| +2,423% | +$3.04M | 0.03% | 683 |
|
|
2023
Q3 | $124K | Buy |
1,159
+23
| +2% | +$2.37K | ﹤0.01% | 2472 |
|
|
2023
Q2 | $112K | Sell |
1,136
-25,511
| -96% | -$2.31M | ﹤0.01% | 2612 |
|
|
2023
Q1 | $2.33M | Buy |
26,647
+437
| +2% | +$41.1K | 0.02% | 861 |
|
|
2022
Q4 | $2.28M | Sell |
26,210
-936
| -3% | -$84.1K | 0.02% | 847 |
|
|
2022
Q3 | $2.05M | Buy |
27,146
+1,100
| +4% | +$89.1K | 0.02% | 865 |
|
|
2022
Q2 | $2.06M | Sell |
26,046
-1,215
| -4% | -$102K | 0.02% | 895 |
|
|
2022
Q1 | $2.39M | Buy |
27,261
+9,655
| +55% | +$994K | 0.02% | 926 |
|
|
2021
Q4 | $1.82M | Hold |
17,606
| – | – | 0.02% | 899 |
|
|
2021
Q3 | $1.62M | Sell |
17,606
-898
| -5% | -$78.7K | 0.01% | 939 |
|
|
2021
Q2 | $1.51M | Sell |
18,504
-1,592
| -8% | -$115K | 0.01% | 975 |
|
|
2021
Q1 | $1.34M | Sell |
20,096
-1,553
| -7% | -$105K | 0.01% | 1003 |
|
|
2020
Q4 | $1.46M | Hold |
21,649
| – | – | 0.01% | 966 |
|
|
2020
Q3 | $1.28M | Buy |
21,649
+1,945
| +10% | +$111K | 0.01% | 921 |
|
|
2020
Q2 | $1.1M | Buy |
19,704
+1,569
| +9% | +$91.4K | 0.01% | 994 |
|
|
2020
Q1 | $945K | Hold |
18,135
| – | – | 0.01% | 924 |
|
|
2019
Q4 | $886K | Hold |
18,135
| – | – | 0.01% | 1153 |
|
|
2019
Q3 | $818K | Buy |
18,135
+3,076
| +20% | +$136K | 0.01% | 1167 |
|
|
2019
Q2 | $671K | Sell |
15,059
-30,118
| -67% | -$1.41M | 0.01% | 1315 |
|
|
2019
Q1 | $2.07M | Buy |
45,177
+30,118
| +200% | +$1.33M | 0.01% | 1236 |
|
|
2018
Q4 | $554K | Buy |
15,059
+1,235
| +9% | +$50.3K | 0.01% | 1305 |
|
|
2018
Q3 | $621K | Hold |
13,824
| – | – | 0.01% | 1393 |
|
|
2018
Q2 | $708K | Buy |
13,824
+1,908
| +16% | +$91.3K | 0.01% | 1194 |
|
|
2018
Q1 | $531K | Hold |
11,916
| – | – | 0.01% | 1334 |
|
|
2017
Q4 | $541K | Buy |
+11,916
| New | +$510K | 0.01% | 1356 |
|
Other funds holding HLI
MetLife Investment Management's HLI Position: Q2 2026 in Review
MetLife Investment Management reduced its Houlihan Lokey (HLI) stake by 5.6% in Q2 2026, selling an estimated $229K and leaving 26,110 shares worth $3.5M. The position accounts for 0.02% of the portfolio, ranked #839.
MetLife Investment Management first reported a position in HLI in Q4 2017 and has held it in 35 quarters since. The position peaked at $5.94M in Q3 2025. 519 funds tracked by Wall St. Rank hold HLI as of Q2 2026.
- MetLife Investment Management held 26,110 shares of Houlihan Lokey worth $3.5M as of Q2 2026.
- MetLife Investment Management sold 1,553 Houlihan Lokey shares in Q2 2026, an estimated $229K.
- Houlihan Lokey made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #839 holding.
- MetLife Investment Management first reported a position in Houlihan Lokey in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's Houlihan Lokey position peaked at $5.94M in Q3 2025.
- 519 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.